Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization for atherosclerosis.

Kuang-Yuh Chyu1, Jan Nilsson, Prediman K Shah

  • 1Division of Cardiology, Cedars Sinai Medical Center, Suite 5531, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

Current Atherosclerosis Reports
|September 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart disease.

Cardiovascular research·2026
Same author

LL-37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults.

Physiological reports·2026
Same author

Development and validation of two brief versions of the Nurse Professional Competence (NPC) Scale: The NPC-6 and NPC-12.

Nurse education today·2026
Same author

Adaptive immune response to the autoantigen LL-37 differentiates atherosclerotic cardiovascular disease phenotypes.

Clinical & translational immunology·2026
Same author

Deletion of PKM2 in Macrophages Promotes Stabilization but Not Regression of Atherosclerotic Plaques.

Circulation research·2026
Same author

Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study.

Cardiovascular diabetology·2026
Same journal

The Spectrum of Genetic Causes of Familial Hypercholesterolemia Phenotype.

Current atherosclerosis reports·2026
Same journal

Targeting LDL Across the Whole Spectrum of Chronic Kidney Disease: From Pathophysiology to Novel Treatments.

Current atherosclerosis reports·2026
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
See all related articles

Developing an atherosclerosis vaccine shows promise by harnessing the immune system's protective capabilities. Further research is needed to optimize this immune-modulation therapy for cardiovascular disease management.

Area of Science:

  • Immunology
  • Cardiovascular Science
  • Vaccine Development

Background:

  • Atherosclerosis involves complex immune system interactions, with potential for both promoting and protecting against disease progression.
  • Immune-modulation strategies, including active or passive immunization, are being explored to target atheroprotective mechanisms.

Purpose of the Study:

  • To review experimental evidence on the immune system's role in atherogenesis.
  • To evaluate the feasibility and effectiveness of immune-modulation therapies for atherosclerosis.
  • To assess the potential of developing an atheroprotective vaccine for clinical application.

Main Methods:

  • Review of experimental findings on immune system involvement in atherosclerosis.
  • Analysis of studies investigating active and passive immunization strategies.

Related Experiment Videos

  • Identification and testing of potential immunogens for atheroprotective efficacy.

    • Main Results:

    • Experimental studies demonstrate the feasibility and effectiveness of immune-modulation for atherosclerosis.
    • Variable results have been observed with different immunogens tested for atheroprotective effects.
    • Several key questions regarding vaccine development, including antigen choice, adjuvants, administration, durability, and safety, remain.

    Conclusions:

    • An immune-based approach, particularly a vaccine, is a potentially viable strategy for managing atherosclerotic cardiovascular disease.
    • Exploiting atheroprotective immune responses offers a promising therapeutic avenue.
    • Further research is essential to address outstanding questions for successful clinical translation.